Collegium Pharmaceutical, Inc. Notes Reduction
Collegium Pharmaceutical, Inc. (COLL) reported Notes Reduction of $5.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-18.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesReduction · last filed 2017-03-10
- Collegium Pharmaceutical, Inc. notes reduction for the quarter ending 2014-12-31 was $0.00.
- Collegium Pharmaceutical, Inc. notes reduction for the quarter ending 2014-09-30 was $0.00.
- Collegium Pharmaceutical, Inc. notes reduction for the quarter ending 2014-06-30 was $0.00.
- Collegium Pharmaceutical, Inc. notes reduction for the quarter ending 2014-03-31 was $944.00K.
- Collegium Pharmaceutical, Inc. notes reduction for fiscal 2015 was $5.00M, a 429.66% increase from fiscal 2014.
- Collegium Pharmaceutical, Inc. notes reduction for fiscal 2014 was $944.00K.
| Period end | Notes Reduction 3 month | Notes Reduction 6 month | Notes Reduction 9 month | Notes Reduction 12 month |
|---|---|---|---|---|
| 2015-12-31 | $5.00M 10-K · filed 2016-03-18 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $0.00 derived: sum of 2 quarters · filed 2017-03-10 | $0.00 derived: sum of 3 quarters · filed 2017-03-10 | $944.00K 10-K · filed 2017-03-10 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $944.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12 | $944.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $944.00K 10-Q/A · filed 2015-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |